{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:49:54Z","timestamp":1790808594410,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse of the NIH","doi-asserted-by":"crossref","award":["2015-PM-BX-K002"],"award-info":[{"award-number":["2015-PM-BX-K002"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse of the NIH","doi-asserted-by":"crossref","award":["Bureau of Justice Assistance"],"award-info":[{"award-number":["Bureau of Justice Assistance"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse of the NIH","doi-asserted-by":"crossref","award":["F31DA047021"],"award-info":[{"award-number":["F31DA047021"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["5T32DA007292-25"],"award-info":[{"award-number":["5T32DA007292-25"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.amepre.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T03:05:51Z","timestamp":1574046351000},"page":"e211-e217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data"],"prefix":"10.1016","volume":"57","author":[{"given":"Lindsey M.","family":"Ferris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-5869","authenticated-orcid":false,"given":"Molly P.","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-4057","authenticated-orcid":false,"given":"Kate","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Casey","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1166-8877","authenticated-orcid":false,"given":"Tom M.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-5946","authenticated-orcid":false,"given":"Klaus W.","family":"Lemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2019.07.026_bib0001","unstructured":"CDC. Drug overdose deaths. www.cdc.gov\/drugoverdose\/data\/statedeaths.html. Updated December 19, 2018. Accessed January 13, 2019."},{"key":"10.1016\/j.amepre.2019.07.026_bib0002","unstructured":"CDC. Opioid overdose: understanding the epidemic. www.cdc.gov\/drugoverdose\/epidemic\/index.html. Updated December 19, 2018. Accessed January 13, 2019."},{"key":"10.1016\/j.amepre.2019.07.026_bib0003","unstructured":"Brandeis University Prescription Drug Monitoring Program Training and Technical Assistance Center. The goals of prescription drug monitoring. www.pdmpassist.org\/pdf\/Prescription_Monitoring_Goals.pdf. Accessed July 22, 2018."},{"issue":"3","key":"10.1016\/j.amepre.2019.07.026_bib0004","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1377\/hlthaff.2014.1085","article-title":"Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access","volume":"34","author":"Rutkow","year":"2015","journal-title":"Health Aff"},{"key":"10.1016\/j.amepre.2019.07.026_bib0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.drugalcdep.2017.08.040","article-title":"Prescription Drug Monitoring Program design and function: a qualitative analysis","volume":"180","author":"Rutkow","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.amepre.2019.07.026_bib0006","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain","volume":"54","author":"Bohnert","year":"2016","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.amepre.2019.07.026_bib0007","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MLR.0000000000000738","article-title":"Patterns of opioid use and risk of opioid overdose death among Medicaid patients","volume":"55","author":"Garg","year":"2017","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.amepre.2019.07.026_bib0008","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/j.pain.0000000000001078","article-title":"High-risk prescribing and opioid overdose: prospects for prescription drug monitoring program-based proactive alerts","volume":"159","author":"Geissert","year":"2018","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.amepre.2019.07.026_bib0009","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2013.12711","article-title":"High-risk use by patients prescribed opioids for pain and its role in overdose deaths","volume":"175","author":"Gwira Baumblatt","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amepre.2019.07.026_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","article-title":"Predictors of opioid-related death during methadone therapy","volume":"57","author":"Leece","year":"2015","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"10.1016\/j.amepre.2019.07.026_bib0011","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.amepre.2019.07.026_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-016-3810-3","article-title":"Association between initial opioid prescribing patterns and subsequent long-term use among opioid-na\u00efve patients: a statewide retrospective cohort study","volume":"32","author":"Deyo","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.amepre.2019.07.026_bib0013","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2019.07.026_bib0014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2019.07.026_bib0015","unstructured":"Maryland Department of Health. Office of the chief medical examiner. https:\/\/health.maryland.gov\/ocme\/Pages\/Home.aspx. Updated 2018. Accessed September 30, 2018."},{"issue":"1","key":"10.1016\/j.amepre.2019.07.026_bib0016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/ser0000099","article-title":"Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide","volume":"14","author":"Oliva","year":"2017","journal-title":"Psychol Serv"},{"issue":"1","key":"10.1016\/j.amepre.2019.07.026_bib0017","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/pm\/pnx009","article-title":"Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database","volume":"19","author":"Zedler","year":"2018","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.amepre.2019.07.026_bib0018","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/add.14068","article-title":"Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers","volume":"113","author":"Chang","year":"2018","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.amepre.2019.07.026_bib0019","first-page":"1137","article-title":"Rule-based classification systems using classification and regression tree (CART) analysis","volume":"67","author":"Lawrence","year":"2001","journal-title":"Photogramm Eng Remote Sens"},{"issue":"7","key":"10.1016\/j.amepre.2019.07.026_bib0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00134-003-1761-8","article-title":"A reader's guide to the interpretation of diagnostic test properties: clinical example of sepsis","volume":"29","author":"Fischer","year":"2003","journal-title":"Intensive Care Med"},{"issue":"6947","key":"10.1016\/j.amepre.2019.07.026_bib0021","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: predictive values","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.amepre.2019.07.026_bib0022","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/pme.12777","article-title":"Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans\u2019 Health Administration patients","volume":"16","author":"Zedler","year":"2015","journal-title":"Pain Med"},{"issue":"11","key":"10.1016\/j.amepre.2019.07.026_bib0023","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3109\/10826084.2015.1018548","article-title":"Exploring prospective predictors of illicit drug-toxicity deaths: evidence from the General Social Survey","volume":"50","author":"Feigelman","year":"2015","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.amepre.2019.07.026_bib0024","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2018.05.004","article-title":"Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data","volume":"190","author":"Nechuta","year":"2018","journal-title":"J Alcohol Drug Depend"},{"key":"10.1016\/j.amepre.2019.07.026_bib0025","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719303502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719303502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:53:17Z","timestamp":1760082797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379719303502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0749379719303502"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2019.07.026","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}